Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat

被引:69
作者
De Angelis, N
Fiordaliso, J
Latini, R
Calvillo, L
Funicello, M
Gobbi, M
Mennini, T
Masson, S
机构
[1] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, I-20157 Milan, Italy
[2] Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, I-20157 Milan, Italy
关键词
angiotensin II; aldosterone; apoptosis; renin angiotensin system; myocytes; AT(1) receptor; isolated cells;
D O I
10.1006/jmcc.2002.2115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite previous observations on isolated ventricular myocytes, there are still few evidences that angiotensin II induces cardiomyocyte apoptosis in vivo. The possibility that aldosterone, the final hormone of the renin-angiotensin-aldosterone system under Ang II control, can stimulate cardiac apoptosis has not yet been explored. Angiotensin II or aldosterone (1 mg/kg each) were infused in adult normotensive rats for different times, and the number of apoptotic ventricular myocyte nuclei was quantified by the TUNEL method, along with caspase-3 activation. The role of angiotensin II type 1 receptor in vivo was assessed by selective blockade with valsartan and ex vivo by binding experiments. In addition, myocytes in primary culture were incubated with Ang II or aldosterone in presence of spironolactone. Continuous infusion of Ang II induced a rapid, AT(1)-mediated increase of apoptotic cardiomyocyte nuclei (from 14 +/- 9 to 188 +/- 35 TdT-labeled nuclei/ 10(6) after 3 h, P < 0.005) and of activated caspase-3, that normalized after 24 h. The normalization was associated with a down-regulation of myocardial AT, receptors. Aldosterone stimulated cardiomyocyte apoptosis both in vivo and in isolated cells, to a similar extent as Ang II. The maximal apoptotic rate reported here (similar to0.02%) and the transient effect of Ang II suggest that myocyte loss by apoptosis is limited in the present model. The data on aldosterone-induced ventricular myocyte apoptosis deserve further attention to delineate the role of aldosterone in cell death and offer possible mechanistic explanations on the benefits afforded by aldosterone receptor antagonists in heart failure. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1655 / 1665
页数:11
相关论文
共 31 条
  • [21] Angiotensin AT1 receptor subtype as a cardiac target of aldosterone -: Role in aldosterone-salt-induced fibrosis
    Robert, V
    Heymes, C
    Silvestre, JS
    Sabri, A
    Swynghedauw, B
    Delcayre, C
    [J]. HYPERTENSION, 1999, 33 (04) : 981 - 986
  • [22] Aldosterone: A mediator of myocardial necrosis and renal arteriopathy
    Rocha, R
    Stier, CT
    Kifor, I
    Ochoa-Maya, MR
    Rennke, HG
    Williams, GH
    Adler, GK
    [J]. ENDOCRINOLOGY, 2000, 141 (10) : 3871 - 3878
  • [23] Morphologic and biochemical hallmarks of apoptosis
    Saraste, A
    Pulkki, K
    [J]. CARDIOVASCULAR RESEARCH, 2000, 45 (03) : 528 - 537
  • [24] The role of cell death in heart failure
    Schaper, J
    Elsässer, A
    Kostin, S
    [J]. CIRCULATION RESEARCH, 1999, 85 (09) : 867 - 869
  • [25] Activation of cardiac aldosterone production in rat myocardial infarction -: Effect of angiotensin II receptor blockade and role in cardiac fibrosis
    Silvestre, JS
    Heymes, C
    Oubénaïssa, A
    Robert, V
    Aupetit-Faisant, B
    Carayon, A
    Swynghedauw, B
    Delcayre, C
    [J]. CIRCULATION, 1999, 99 (20) : 2694 - 2701
  • [26] Myocardial production of aldosterone and corticosterone in the rat - Physiological regulation
    Silvestre, JS
    Robert, V
    Heymes, C
    Aupetit-Faisant, B
    Mouas, C
    Moalic, JM
    Swynghedauw, B
    Delcayre, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 4883 - 4891
  • [27] Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice
    Sugino, H
    Ozono, R
    Kurisu, S
    Matsuura, H
    Ishida, M
    Oshima, T
    Kambe, M
    Teranishi, Y
    Masaki, H
    Matsubara, H
    [J]. HYPERTENSION, 2001, 37 (06) : 1394 - 1398
  • [28] SUN Y, 1993, J LAB CLIN MED, V122, P404
  • [29] Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure
    Tsutamoto, T
    Wada, A
    Maeda, K
    Mabuchi, N
    Hayashi, M
    Tsutsui, T
    Ohnishi, M
    Sawaki, M
    Fujii, M
    Matsumoto, T
    Horie, H
    Sugimoto, Y
    Kinoshita, M
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 838 - 844
  • [30] CHRONIC MINERALOCORTICOID EXCESS AND CARDIOVASCULAR REMODELING
    WEBER, KT
    SUN, Y
    CAMPBELL, SE
    SLIGHT, SH
    GANJAM, VK
    GRIFFING, GT
    SWINFARD, RW
    DIAZARIAS, AA
    [J]. STEROIDS, 1995, 60 (01) : 125 - 132